Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2022 Volume 23 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2022 Volume 23 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types

  • Authors:
    • Lijing Jia
    • Peilin Zheng
    • Hongbo Wang
    • Lin Kang
    • Han Wu
    • Xiaobing Fu
  • View Affiliations / Copyright

    Affiliations: Laboratory of Wound Healing and Cell Biology, Institute of Basic Medical Science, Chinese People's Liberation Army General Hospital, Beijing 100048, P.R. China, Department of Endocrinology, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong 518020, P.R. China, Department of Respiratory Medicine, Tianjin Children's Hospital, Tianjin 300134, P.R. China
    Copyright: © Jia et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 251
    |
    Published online on: January 31, 2022
       https://doi.org/10.3892/etm.2022.11176
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Lower limb ischemia caused by diabetic foot (DF) is one of the most serious complications of diabetes. The therapeutic role of VEGF in DF is well documented. However, the mechanism for action of VEGF is still not clear. The present study aimed to explore the effects of VEGF‑mediated skeletal muscle fiber type switch in angiogenesis and the treatment of DF. C57BL/6 mice housed in cages equipped with a voluntary running wheel were used to access VEGF protein level and citrate synthase activity (by ELISA) as well as muscle fiber type changes (by immunofluorescence) in the gastrocnemius muscle. C57BL/6 mice were fed on a high‑fat diet for 6 weeks and then injected with streptozocin to induce diabetic lower limb ischemia model. Control adenovirus (Ad‑GFP) or Ad‑VEGF‑GFP were then injected into the left gastrocnemius of the ischemic diabetic mice. Blood flow perfusion was examined by laser Doppler imaging at 1, 3, 7 and 14 days after adenovirus transduction. On day 14, all mice were anesthetized and sacrificed. VEGF expression levels, citrate synthase activity and muscle fiber type changes in the gastrocnemius muscle were assayed by ELISA and immunofluorescence analysis of myosin heavy chain IIa (MHCIIa) expression, respectively. Transwell assays were performed to determine whether VEGF‑treated C2C12 myotubes played a role on tubule formation and migration of HUVECs. It was found that VEGF levels and citrate synthase activity were upregulated after voluntary exercise, along with the increased frequency of oxidized muscle fibers. Notably, adenovirus‑mediated VEGF overexpression in the muscle also increased the frequency of oxidized (MHCIIa‑positive) muscle fibers, enhanced citrate synthase activity and ameliorated lower limb ischemia in diabetic mice. VEGF treatment enhanced the phosphorylation of PI3K, Akt and AMPK (assayed by western blotting), as well as glucose consumption and metabolism (assayed by western blotting and glucose uptake assay), in the C2C12 myotubes. Interestingly, VEGF‑treated C2C12 myotubes promoted the migration and tubule formation of HUVEC cells. The present findings suggest that skeletal muscle fiber conversion might be a potential approach for VEGF‑mediated angiogenesis and disease treatment, which may provide new options for the prevention and treatment of DF.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Boulton AJ, Vileikyte L, Ragnarson-Tennvall G and Apelqvist J: The global burden of diabetic foot disease. Lancet. 366:1719–1724. 2005.PubMed/NCBI View Article : Google Scholar

2 

Johannesson A, Larsson GU, Ramstrand N, Turkiewicz A, Wiréhn AB and Atroshi I: Incidence of lower-limb amputation in the diabetic and nondiabetic general population: A 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations. Diabetes Care. 32:275–280. 2009.PubMed/NCBI View Article : Google Scholar

3 

Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, Urbancic V, Bakker K, Holstein P, et al: Prediction of outcome in individuals with diabetic foot ulcers: Focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia. 51:747–755. 2008.PubMed/NCBI View Article : Google Scholar

4 

Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, et al: High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 50:18–25. 2007.PubMed/NCBI View Article : Google Scholar

5 

American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 26:3333–3341. 2003.PubMed/NCBI View Article : Google Scholar

6 

Guo X, Shi Y, Huang X, Ye M, Xue G and Zhang J: Features analysis of lower extremity arterial lesions in 162 diabetes patients. J Diabetes Res. 2013(781360)2013.PubMed/NCBI View Article : Google Scholar

7 

Adams V and Linke A: Impact of exercise training on cardiovascular disease and risk. Biochim Biophys Acta Mol Basis Dis. 1865:728–734. 2019.PubMed/NCBI View Article : Google Scholar

8 

Brevetti G, Silvestro A, Schiano V and Chiariello M: Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 108:2093–2098. 2003.PubMed/NCBI View Article : Google Scholar

9 

Daiber A, Steven S, Weber A, Shuvaev VV, Muzykantov VR, Laher I, Li H, Lamas S and Münzel T: Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 174:1591–1619. 2017.PubMed/NCBI View Article : Google Scholar

10 

Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:983–985. 1983.PubMed/NCBI View Article : Google Scholar

11 

Germani A, Di Carlo A, Mangoni A, Straino S, Giacinti C, Turrini P, Biglioli P and Capogrossi MC: Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol. 163:1417–1428. 2003.PubMed/NCBI View Article : Google Scholar

12 

Yan Z, Okutsu M, Akhtar YN and Lira VA: Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle. J Appl Physiol (1985). 110:264–274. 2011.PubMed/NCBI View Article : Google Scholar

13 

Oberbach A, Bossenz Y, Lehmann S, Niebauer J, Adams V, Paschke R, Schön MR, Blüher M and Punkt K: Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care. 29:895–900. 2006.PubMed/NCBI View Article : Google Scholar

14 

Picard M, Hepple RT and Burelle Y: Mitochondrial functional specialization in glycolytic and oxidative muscle fibers: Tailoring the organelle for optimal function. Am J Physiol Cell Physiol. 302:C629–C641. 2012.PubMed/NCBI View Article : Google Scholar

15 

van Weel V, Deckers MML, Grimbergen JM, van Leuven KJ, Lardenoye JH, Schlingemann RO, van Nieuw Amerongen GP, van Bockel JH, van Hinsbergh VW and Quax PH: Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo. Circ Res. 95:58–66. 2004.PubMed/NCBI View Article : Google Scholar

16 

McGrath JC and Lilley E: Implementing guidelines on reporting research using animals (ARRIVE etc.): New requirements for publication in BJP. Br J Pharmacol. 172:3189–3193. 2015.PubMed/NCBI View Article : Google Scholar

17 

Novak CM, Burghardt PR and Levine JA: The use of a running wheel to measure activity in rodents: Relationship to energy balance, general activity, and reward. Neurosci Biobehav Rev. 36:1001–1014. 2012.PubMed/NCBI View Article : Google Scholar

18 

Waters RE, Rotevatn S, Li P, Annex BH and Yan Z: Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle. Am J Physiol Cell Physiol. 287:C1342–C1348. 2004.PubMed/NCBI View Article : Google Scholar

19 

Thinakaran G, Ojala J and Bag J: Expression of c-jun/AP-1 during myogenic differentiation in mouse C2C12 myoblasts. FEBS Lett. 319:271–276. 1993.PubMed/NCBI View Article : Google Scholar

20 

Jensen EC: Quantitative analysis of histological staining and fluorescence using ImageJ. Anat Rec (Hoboken). 296:378–381. 2013.PubMed/NCBI View Article : Google Scholar

21 

Padgett ME, McCord TJ, McClung JM and Kontos CD: methods for acute and subacute murine hindlimb Ischemia. J Vis Exp. 112(54166)2016.PubMed/NCBI View Article : Google Scholar

22 

Tokudome T, Kishimoto I, Yamahara K, Osaki T, Minamino N, Horio T, Sawai K, Kawano Y, Miyazato M, Sata M, et al: Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides. Arterioscler Thromb Vasc Biol. 29:1516–1521. 2009.PubMed/NCBI View Article : Google Scholar

23 

Jockusch H and Eberhard D: Green fluorescent protein as a tracer in chimeric tissues: The power of vapor fixation. Methods Mol Biol. 411:145–154. 2007.PubMed/NCBI View Article : Google Scholar

24 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

25 

Ariyanti AD, Sisjayawan J, Zhang J, Zhang JQ, Wang GX, Miyagishi M, Wu SR and Kasim V: Elevating VEGF-A and PDGF-BB secretion by salidroside enhances neoangiogenesis in diabetic hind-limb ischemia. Oncotarget. 8:97187–97205. 2017.PubMed/NCBI View Article : Google Scholar

26 

Liu N, Ding D, Hao W, Yang F, Wu X, Wang M, Xu X, Ju Z, Liu JP, Song Z, et al: hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor. Nucleic Acids Res. 44:8693–8703. 2016.PubMed/NCBI View Article : Google Scholar

27 

Delavar H, Nogueira L, Wagner PD, Hogan MC, Metzger D and Breen EC: Skeletal myofiber VEGF is essential for the exercise training response in adult mice. Am J Physiol Regul Integr Comp Physiol. 306:R586–R595. 2014.PubMed/NCBI View Article : Google Scholar

28 

Huh JY: The role of exercise-induced myokines in regulating metabolism. Arch Pharm Res. 41:14–29. 2018.PubMed/NCBI View Article : Google Scholar

29 

Pedersen BK and Febbraio MA: Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol. 8:457–465. 2012.PubMed/NCBI View Article : Google Scholar

30 

Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, Lin JD, Greenberg ME and Spiegelman BM: Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab. 18:649–659. 2013.PubMed/NCBI View Article : Google Scholar

31 

Birot OJG, Koulmann N, Peinnequin A and Bigard XA: Exercise-induced expression of vascular endothelial growth factor mRNA in rat skeletal muscle is dependent on fibre type. J Physiol. 552:213–221. 2003.PubMed/NCBI View Article : Google Scholar

32 

Cannon DT, Rodewohl L, Adams V, Breen EC and Bowen TS: Skeletal myofiber VEGF deficiency leads to mitochondrial, structural, and contractile alterations in mouse diaphragm. J Appl Physiol (1985). 127:1360–1369. 2019.PubMed/NCBI View Article : Google Scholar

33 

Leick L, Hellsten Y, Fentz J, Lyngby SS, Wojtaszewski JF, Hidalgo J and Pilegaard H: PGC-1alpha mediates exercise-induced skeletal muscle VEGF expression in mice. Am J Physiol Endocrinol Metab. 297:E92–E103. 2009.PubMed/NCBI View Article : Google Scholar

34 

Matsakas A, Yadav V, Lorca S, Evans RM and Narkar VA: Revascularization of ischemic skeletal muscle by estrogen-related receptor-γ. Circ Res. 110:1087–1096. 2012.PubMed/NCBI View Article : Google Scholar

35 

Mishra P, Varuzhanyan G, Pham AH and Chan DC: Mitochondrial dynamics is a distinguishing feature of skeletal muscle fiber types and regulates organellar compartmentalization. Cell Metab. 22:1033–1044. 2015.PubMed/NCBI View Article : Google Scholar

36 

Hood DA, Memme JM, Oliveira AN and Triolo M: Maintenance of skeletal muscle mitochondria in health, exercise, and aging. Annu Rev Physiol. 81:19–41. 2019.PubMed/NCBI View Article : Google Scholar

37 

Fernandez-Marcos PJ and Auwerx J: Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr. 93 (Suppl):884S–890S. 2011.PubMed/NCBI View Article : Google Scholar

38 

Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe GC, Sawada N, Raghuram S and Arany Z: The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc Natl Acad Sci USA. 106:21401–21406. 2009.PubMed/NCBI View Article : Google Scholar

39 

Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, Lebrasseur NK, Yan Z and Spiegelman BM: Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J Biol Chem. 282:30014–30021. 2007.PubMed/NCBI View Article : Google Scholar

40 

Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, et al: Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 418:797–801. 2002.PubMed/NCBI View Article : Google Scholar

41 

Zhao Y, Li X, Yang L, Eckel-Mahan K, Tong Q, Gu X, Kolonin MG and Sun K: Transient overexpression of vascular endothelial growth factor a in adipose tissue promotes energy expenditure via activation of the sympathetic nervous system. Mol Cell Biol. 38:e00242–18. 2018.PubMed/NCBI View Article : Google Scholar

42 

Liu X, Chu B, Jin S, Li M, Xu Y, Yang H, Feng Z, Bi J and Wang P: Vascular endothelial growth factor alleviates mitochondrial dysfunction and suppression of mitochondrial biogenesis in models of Alzheimer's disease. Int J Neurosci. 131:154–162. 2021.PubMed/NCBI View Article : Google Scholar

43 

Wright GL, Maroulakou IG, Eldridge J, Liby TL, Sridharan V, Tsichlis PN and Muise-Helmericks RC: VEGF stimulation of mitochondrial biogenesis: Requirement of AKT3 kinase. FASEB J. 22:3264–3275. 2008.PubMed/NCBI View Article : Google Scholar

44 

Mészáros K, Lang CH, Bagby GJ and Spitzer JJ: Contribution of different organs to increased glucose consumption after endotoxin administration. J Biol Chem. 262:10965–10970. 1987.PubMed/NCBI

45 

Evans PL, McMillin SL, Weyrauch LA and Witczak CA: Regulation of skeletal muscle glucose transport and glucose metabolism by exercise training. Nutrients. 11(2432)2019.PubMed/NCBI View Article : Google Scholar

46 

Gaster M, Beck-Nielsen H and Schroder H: Regenerating human muscle fibres express GLUT3 protein. Pflügers Arch. 445:105–114. 2002.PubMed/NCBI View Article : Google Scholar

47 

Gaster M, Franch J, Staehr P, Beck-Nielsen H, Smith T and Schroder H: Induction of GLUT-1 protein in adult human skeletal muscle fibers. Am J Physiol Endocrinol Metab. 279:E1191–E1195. 2000.PubMed/NCBI View Article : Google Scholar

48 

Goodyear LJ, Hirshman MF, Smith RJ and Horton ES: Glucose transporter number, activity, and isoform content in plasma membranes of red and white skeletal muscle. Am J Physiol Endocrinol Metab. 261:E556–E561. 1991.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jia L, Zheng P, Wang H, Kang L, Wu H and Fu X: VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types. Exp Ther Med 23: 251, 2022.
APA
Jia, L., Zheng, P., Wang, H., Kang, L., Wu, H., & Fu, X. (2022). VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types. Experimental and Therapeutic Medicine, 23, 251. https://doi.org/10.3892/etm.2022.11176
MLA
Jia, L., Zheng, P., Wang, H., Kang, L., Wu, H., Fu, X."VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types". Experimental and Therapeutic Medicine 23.4 (2022): 251.
Chicago
Jia, L., Zheng, P., Wang, H., Kang, L., Wu, H., Fu, X."VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types". Experimental and Therapeutic Medicine 23, no. 4 (2022): 251. https://doi.org/10.3892/etm.2022.11176
Copy and paste a formatted citation
x
Spandidos Publications style
Jia L, Zheng P, Wang H, Kang L, Wu H and Fu X: VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types. Exp Ther Med 23: 251, 2022.
APA
Jia, L., Zheng, P., Wang, H., Kang, L., Wu, H., & Fu, X. (2022). VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types. Experimental and Therapeutic Medicine, 23, 251. https://doi.org/10.3892/etm.2022.11176
MLA
Jia, L., Zheng, P., Wang, H., Kang, L., Wu, H., Fu, X."VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types". Experimental and Therapeutic Medicine 23.4 (2022): 251.
Chicago
Jia, L., Zheng, P., Wang, H., Kang, L., Wu, H., Fu, X."VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types". Experimental and Therapeutic Medicine 23, no. 4 (2022): 251. https://doi.org/10.3892/etm.2022.11176
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team